Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04356261
Other study ID # LMU IRB 2019 SP 49-R
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date August 15, 2021
Est. completion date May 30, 2024

Study information

Verified date April 2023
Source Loyola Marymount University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Personalized Normative Feedback (PNF), the most widely-used college alcohol intervention approach, suffers from several limitations innovatively remedied in the current proposal through CampusGANDR, a smartphone-based app for college students that delivers alcohol-related PNF within a weekly game centered around testing first-year students' perceptions about the attitudes and behaviors of their peers in a variety of campus-relevant domains. Five pilot studies suggest that CampusGANDR will be significantly more effective at correcting students' normative misperceptions and reducing their alcohol use than standard PNF, especially among heavier-drinking students and those with greater exposure to alcohol on social media, and that these larger effects are driven by the significantly decreased psychological reactance experienced by students when viewing feedback as part of a game about college life rather than as part of an alcohol-focused program. The current project seeks to 1) evaluate the efficacy of CampusGANDR in a large-scale multi-site trial, 2) identify the optimal dosage of alcohol feedback to deliver within CampusGANDR for correcting norms and reducing alcohol use across 12 weeks of gameplay among non-drinking, moderate-drinking, and heavy-drinking students, 3) examine person-level moderators of these effects, and 4) evaluate CampusGANDR engagement and sustainability among students who play voluntarily but are not involved in the randomized controlled trial.


Description:

Despite concerted efforts, high risk drinking remains a significant problem on college campuses. Further, the transition into college is an identified critical period in which risky drinking patterns are often established and serious negative consequences occur. Colleges commonly employ Normative Re-Education (NR), a promising intervention approach focused on correcting over-estimated peer drinking norms, to reduce alcohol risk in first-year students. However, the most cost-effective and scalable NR intervention strategy, web-based personalized normative feedback (PNF), has yielded only modest reductions in drinking. Several issues have been identified that may explain these relatively small effects. For example, students often question the credibility of the normative data, the content fails to capture students' attention, and heavy drinkers often react to feedback defensively. These issues are not surprising as, unlike social media and digital gaming applications that capture and sustain young adults' attention, web-based PNF formats lack the sophisticated digital graphics, social interactivity, and other dynamic features to which students have become accustomed. Further, colleges often make participation mandatory or offer incentives to enroll students in current interventions, likely a detriment to student motivation and thus intervention effectiveness. CampusGANDR (Gamified Alcohol Norm Discovery and Re-education) addresses these issues by delivering alcohol PNF within a fun, gamified smartphone app that tests first-year students' perceptions of college life and classmates' attitudes and behaviors on a weekly basis across the first semester of college. Integrating features from popular social media platforms and evidence-based digital game mechanics (e.g., co-presence, a wager-based system of points, and chance-based uncertainty), CampusGANDR also features enhanced PNF and includes several novel features informed by longstanding cognitive and social psychological theories. Based on extensive pilot work, the current proposal seeks to: 1) evaluate the efficacy of CampusGANDR in a large-scale multi-site randomized controlled trial (RCT); 2) identify the optimal dosage of alcohol feedback to deliver within CampusGANDR for correcting norms and reducing alcohol use among students who differ in alcohol use (non-drinkers, light to moderate drinkers, and heavy drinkers); 3) examine person-level moderators of intervention efficacy; and 4) evaluate CampusGANDR engagement and the sustainability of play among students who use the app but aren't recruited into the evaluation study (RCT). At two distinctly different campuses (Loyola Marymount University and the University of Houston) 3 consecutive cohorts of first-year students will be invited to download the CampusGANDR app to test their perceptions of campus life compete against their classmates. Then, among students already playing CampusGANDR, a balanced sub-sample of 1,800 non-drinking, light/moderate drinking, and heavy drinking students (300 students per site per year) will be invited to take part in an evaluation study (RCT). Study participants will play CampusGANDR over the initial 12 weeks of the fall semester and complete 4 surveys assessing their alcohol use, social media use, health behaviors, mental health, and adjustment to college. Study participants will be discretely randomized to receive alcohol feedback 0%, 33%, or 67% of weekly CampusGANDR rounds through a backend manipulation of chance elements. Students not meeting study eligibility criteria and those not electing to take part in the evaluation study will still take part in CampusGANDR. The dosage of alcohol feedback among these non-RCT players receive will be determined at random and their app usage data will be employed to assess app engagement and sustainability of play in the absence of study incentives. This project aims to culminate in a highly engaging, scalable, cutting-edge native smartphone app (IOS, Android) able to dynamically tailor the dosage of alcohol feedback delivered based on students' alcohol experience at the point of matriculation.


Recruitment information / eligibility

Status Recruiting
Enrollment 1800
Est. completion date May 30, 2024
Est. primary completion date April 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 20 Years
Eligibility To play CampusGANDR individuals must: 1. Have access to either a smartphone or a computer with internet capabilities on which the app can be accessed 2. Be at least 18 years of age and currently enrolled as an incoming first-year student at one of the two study sites. 3. Accept CampusGANDR Terms of Service & Privacy Policy. Additional RCT Inclusion Criteria To take part in the evaluation study participants must: 1. Be a CampusGANDR user between 18 and 20 years old 2. Answer screening questions and screen into an open stratum 3. Review and accept the evaluation study Informed Consent form Exclusion criteria for both: 1. Not meeting inclusion criteria 2. Unwillingness to participate (indicated by failure to accept Terms of Service & Privacy Policy, or provide informed consent)

Study Design


Intervention

Behavioral:
Gamified Personalized Normative Feedback
Each week, all players will answer 3 questions of interest about first-year students' attitudes and behaviors (e.g., drinking, partying, exercising, studying, dorm life, etc.) generated by the student players. They will also guess how the typical same-sex student at their University answered the same questions and wager points on how close to the correct answer (group norm) each of their guesses is. Further, they will rate (e.g., thumbs up/thumbs down) the reported behaviors of other players and, then, submit and vote on questions for subsequent rounds. At the end of each week, players will receive enhanced personalized normative feedback feedback on two of the three questions, and receive feedback on how other students rated the answer they reported (preferred-sex injunctive norms).

Locations

Country Name City State
United States Loyola Marymount University Los Angeles California

Sponsors (2)

Lead Sponsor Collaborator
Loyola Marymount University University of Houston

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other CampusGANDR number of student sign-ups per cohort per site percentage of each class at each University who downloaded the app and created an account following the cohort's 17 week long CampusGANDR competition
Other average number of CampusGANDR rounds played per non-RCT user the average number of rounds played by each app user not taking part in the evaluation study following the cohort's 17 week long CampusGANDR competition
Primary Change from Baseline Daily Drinking at 4 Months Assesses number of drinks consumed during an average week over the past month baseline, 4 months
Primary Change from Baseline Daily Drinking at 9 Months Assesses number of drinks consumed during an average week over the past month baseline, 9 months
Primary Change from Baseline Daily Drinking at 12 Months Assesses number of drinks consumed during an average week over the past month baseline, 12 months
Primary Change from Baseline Alcohol Consequences at 4 Months Assesses experience of negative alcohol outcomes baseline, 4 months
Primary Change from Baseline Alcohol Consequences at 9 Months Assesses experience of negative alcohol outcomes baseline, 9 months
Primary Change from Baseline Alcohol Consequences at 12 Months Assesses experience of negative alcohol outcomes baseline, 12 months
Primary Change from Baseline Quantity/Frequency/Peak Alcohol Use at 4 Months Assesses frequency and quantity of alcohol consumption over the past month baseline, 4 months
Primary Change from Baseline Quantity/Frequency/Peak Alcohol Use at 9 Months Assesses frequency and quantity of alcohol consumption over the past month baseline, 9 months
Primary Change from Baseline Quantity/Frequency/Peak Alcohol Use at 12 Months Assesses frequency and quantity of alcohol consumption over the past month baseline, 12 months
Secondary Change from Baseline Descriptive Peer Drinking Norms- Drinking Norms Rating Form at 4 Months Assesses perceptions of weekly alcohol consumption among peers over the past month baseline, 4 months
Secondary Change from Baseline Descriptive Peer Drinking Norms- Drinking Norms Rating Form at 9 Months Assesses perceptions of weekly alcohol consumption among peers over the past month baseline, 9 months
Secondary Change from Baseline Descriptive Peer Drinking Norms- Drinking Norms Rating Form at 12 Months Assesses perceptions of weekly alcohol consumption among peers over the past month baseline, 12 months
Secondary Change from Baseline Descriptive Peer Drinking Norms- Modified Quantity, Frequency, Peak Index at 4 Months Assesses perceptions of peers' frequency and quantity of drinking over the past month baseline, 4 months
Secondary Change from Baseline Descriptive Peer Drinking Norms- Modified Quantity, Frequency, Peak Index at 9 Months Assesses perceptions of peers' frequency and quantity of drinking over the past month baseline, 9 months
Secondary Change from Baseline Descriptive Peer Drinking Norms- Modified Quantity, Frequency, Peak Index at 12 Months Assesses perceptions of peers' frequency and quantity of drinking over the past month baseline, 12 months
Secondary Change from Baseline Injunctive Peer Drinking Norms (adapted from Baer, 1994) at 4 Months Assesses perceptions of peer approval for underage drinking behaviors and experiences baseline, 4 months
Secondary Change from Baseline Injunctive Peer Drinking Norms (adapted from Baer, 1994) at 9 Months Assesses perceptions of peer approval for underage drinking behaviors and experiences baseline, 9 months
Secondary Change from Baseline Injunctive Peer Drinking Norms (adapted from Baer, 1994) at 12 Months Assesses perceptions of peer approval for underage drinking behaviors and experiences baseline, 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04788004 - Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
Recruiting NCT05684094 - Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function N/A
Completed NCT03406039 - Testing the Efficacy of an Online Integrated Treatment for Comorbid Alcohol Misuse and Emotional Problems N/A
Completed NCT03573167 - Mobile Phone-Based Motivational Interviewing in Kenya N/A
Completed NCT04817410 - ED Initiated Oral Naltrexone for AUD Phase 1
Active, not recruiting NCT04267692 - Harm Reduction Talking Circles for American Indians and Alaska Natives With Alcohol Use Disorders N/A
Completed NCT03872128 - The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders Phase 1
Recruiting NCT06030154 - Amplification of Positivity for Alcohol Use N/A
Active, not recruiting NCT05419128 - Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19 N/A
Completed NCT04564807 - Testing an Online Insomnia Intervention N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04203966 - Mental Health and Well-being of People Who Seek Help From Their Member of Parliament
Recruiting NCT05861843 - Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Enrolling by invitation NCT04128761 - Decreasing the Temporal Window in Individuals With Alcohol Use Disorder N/A
Not yet recruiting NCT06337721 - Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Enrolling by invitation NCT02544581 - Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare N/A
Completed NCT02511886 - A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder Phase 2
Active, not recruiting NCT02185131 - Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. Phase 2